{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:06:27Z","timestamp":1791176787951,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,5,1]]},"DOI":"10.1038\/sj.leu.2402485","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:32:24Z","timestamp":1031164344000},"page":"902-910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes"],"prefix":"10.1038","volume":"16","author":[{"given":"PH","family":"O'Donnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-X","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CP","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BJ","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,5,2]]},"reference":[{"key":"BF2402485_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199808273390907","volume":"339","author":"CH Pui","year":"1998","unstructured":"Pui CH, Evans WE . Acute lymphoblastic leukemia N Engl J Med 1998 339: 605\u2013615","journal-title":"N Engl J Med"},{"key":"BF2402485_CR2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/blood.V85.2.359.359","volume":"85","author":"D Delia","year":"1995","unstructured":"Delia D, Aiello A, Formelli F, Fontanella E, Costa A, Miyashita T, Reed JC, Pierotti MA . Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2 Blood 1995 85: 359\u2013367","journal-title":"Blood"},{"key":"BF2402485_CR3","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1093\/jnci\/87.22.1674","volume":"87","author":"GP Kalemkerian","year":"1995","unstructured":"Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M . Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines J Natl Cancer Inst 1995 87: 1674\u20131680","journal-title":"J Natl Cancer Inst"},{"key":"BF2402485_CR4","first-page":"1345","volume":"4","author":"C-P Zou","year":"1998","unstructured":"Zou C-P, Kurie JM, Lotan D, Zou C-C, Hong WK, Lotan R . Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines Clin Cancer Res 1998 4: 1345\u20131355","journal-title":"Clin Cancer Res"},{"key":"BF2402485_CR5","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jnci\/91.13.1138","volume":"91","author":"BJ Maurer","year":"1999","unstructured":"Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, Reynolds CP . Increase of ceramide and induction of mixed apoptosis\/necrosis by N-(4-Hydroxyphenyl)-retinamide in neuroblastoma cell lines J Natl Cancer Inst 1999 91: 1138\u20131146","journal-title":"J Natl Cancer Inst"},{"key":"BF2402485_CR6","first-page":"853","volume":"55","author":"M Ponzoni","year":"1995","unstructured":"Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Raffaghello L, Rozzo C, Montaldo PG . Differential effects of N-(4-hydro-xyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation Cancer Res 1995 55: 853\u2013861","journal-title":"Cancer Res"},{"key":"BF2402485_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/ijc.2910590322","volume":"59","author":"A Di Vinci","year":"1994","unstructured":"Di Vinci A, Geido E, Infusini E, Giaretti W . Neuroblastomacell apoptosis induced by the synthetic retinoidN-(4-hydroxyphenyl)retinamide Int J Cancer 1994 59: 422\u2013426","journal-title":"Int J Cancer"},{"key":"BF2402485_CR8","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/jnci\/86.16.1245","volume":"86","author":"A Mariotti","year":"1994","unstructured":"Mariotti A, Marcora E, Bunone G, Costa A, Veronesi U, Pierotti MA, Della Valle G . N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells J Natl Cancer Inst 1994 86: 1245\u20131247","journal-title":"J Natl Cancer Inst"},{"key":"BF2402485_CR9","first-page":"2005","volume":"14","author":"Y Ziv","year":"1994","unstructured":"Ziv Y, Gupta MK, Milsom JW, Vladisavljevic A, Brand M, Fazio VW . The effect of tamoxifen and fenretinimide on human colorectal cancer cell lines in vitro Anticancer Res 1994 14: 2005\u20132009","journal-title":"Anticancer Res"},{"key":"BF2402485_CR10","first-page":"464","volume":"118","author":"RL Scher","year":"1998","unstructured":"Scher RL, Saito W, Dodge RK, Richtsmeier WJ, Fine RL . Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines Otolaryngol Head Neck Surg 1998 118: 464\u2013471","journal-title":"Otolaryngol Head Neck Surg"},{"key":"BF2402485_CR11","first-page":"1056","volume":"56","author":"SM Kazmi","year":"1996","unstructured":"Kazmi SM, Plante RK, Visconti V, Lau CY . Comparison ofN-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines Cancer Res 1996 56: 1056\u20131062","journal-title":"Cancer Res"},{"key":"BF2402485_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000218012","volume":"18","author":"D Coradini","year":"1997","unstructured":"Coradini D, Biffi A, Pellizzaro C, Pirronello E, Di Fronzo G . Combined effect of tamoxifen or interferon-\u03b2 and 4-hydroxyphenylretinamide on the growth of breast cancer cell lines Tumor Biol 1997 18: 22\u201329","journal-title":"Tumor Biol"},{"key":"BF2402485_CR13","first-page":"499","volume":"37","author":"TC Hsieh","year":"1995","unstructured":"Hsieh TC, Ng C, Wu JM . The synthetic retinoid N-(4-hydro-xyphenyl)retinamide (4-HPR) exerts antiproliferative and apoptosis-inducing effects in the androgen-independent human prostatic JCA-1 cells Biochem Mol Biol Int 1995 37: 499\u2013506","journal-title":"Biochem Mol Biol Int"},{"key":"BF2402485_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/pros.2990240605","volume":"24","author":"M Igawa","year":"1994","unstructured":"Igawa M, Tanabe T, Chodak GW, Rukstalis DB . N-(4-hydro-xyphenyl) retinamide induces cell cycle specific growth inhibition in PC3 cells Prostate 1994 24: 299\u2013305","journal-title":"Prostate"},{"key":"BF2402485_CR15","first-page":"101","volume":"8","author":"KM Roberson","year":"1997","unstructured":"Roberson KM, Penland SN, Padilla GM, Selvan RS, Kim CS, Fine RL, Robertson CN . Fenretinide: induction of apoptosis and endogenous transforming growth factor \u03b2 in PC-3 prostate cancer cells Cell Growth Differ 1997 8: 101\u2013111","journal-title":"Cell Growth Differ"},{"key":"BF2402485_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/(SICI)1097-0045(19971001)33:2<97::AID-PROS3>3.0.CO;2-J","volume":"33","author":"TC Hsieh","year":"1997","unstructured":"Hsieh TC, Wu JM . Effects of fenretinide (4-HPR) on prostate LNCaP cell growth, apoptosis, and prostate-specific gene expression Prostate 1997 33: 97\u2013104","journal-title":"Prostate"},{"key":"BF2402485_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/(SICI)1097-0215(19960208)65:4<491::AID-IJC17>3.0.CO;2-D","volume":"65","author":"R Supino","year":"1996","unstructured":"Supino R, Crosti M, Clerici M, Warlters A, Cleris L, Zunino F, Formelli F . Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression Int J Cancer 1996 65: 491\u2013497","journal-title":"Int J Cancer"},{"key":"BF2402485_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/jnci\/90.8.597","volume":"90","author":"AL Sabichi","year":"1998","unstructured":"Sabichi AL, Hendricks DT, Bober MA, Birrer MJ . Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide J Natl Cancer Inst 1998 90: 597\u2013605","journal-title":"J Natl Cancer Inst"},{"key":"BF2402485_CR19","first-page":"5374","volume":"53","author":"F Formelli","year":"1993","unstructured":"Formelli F, Cleris L . Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity Cancer Res 1993 53: 5374\u20135376","journal-title":"Cancer Res"},{"key":"BF2402485_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jcb.240590911","volume":"23","author":"N Oridate","year":"1995","unstructured":"Oridate N, Lotan D, Mitchell MF, Hong WK, Lotan R . Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention J Cell Biochem Suppl 1995 23: 80\u201386","journal-title":"J Cell Biochem Suppl"},{"key":"BF2402485_CR21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/jnci\/89.16.1191","volume":"89","author":"N Oridate","year":"1997","unstructured":"Oridate N, Suzuki S, Higuchi M, Mitchell MF, Hong WK, Lotan R . Involvement of reactive oxygen species in N-(4-hydro-xyphenyl)retinamide-induced apoptosis in cervical carcinoma cells J Natl Cancer Inst 1997 89: 1191\u20131198","journal-title":"J Natl Cancer Inst"},{"key":"BF2402485_CR22","first-page":"6036","volume":"53","author":"D Delia","year":"1993","unstructured":"Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Formelli F, Menard S, Costa A, Veronesi U . N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid Cancer Res 1993 53: 6036\u20136041","journal-title":"Cancer Res"},{"key":"BF2402485_CR23","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1182\/blood.V87.5.1939.1939","volume":"87","author":"L Benedetti","year":"1996","unstructured":"Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti Passerini C, Adamo S, Levin AA, Pelicci PG, Nervi C . Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase Blood 1996 87: 1939\u20131950","journal-title":"Blood"},{"key":"BF2402485_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0304-3835(98)00071-8","volume":"128","author":"LN Springer","year":"1998","unstructured":"Springer LN, Stewart BW . N-(4-hydroxyphenyl)retinamide-induced death in human lymphoblastoid cells: 50\u2009kb DNA breakage as a means of distinguishing apoptosis from necrosis Cancer Lett 1998 128: 189\u2013196","journal-title":"Cancer Lett"},{"key":"BF2402485_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/10428199709114166","volume":"25","author":"LN Chan","year":"1997","unstructured":"Chan LN, Zhang S, Shao J, Waikel R, Thompson EA, Chan TS . N-(4-hydroxyphenyl)retinamide induced apoptosis in T lymphoma and T lymphoblastoid leukemia cells Leuk Lymphoma 1997 25: 271\u2013280","journal-title":"Leuk Lymphoma"},{"key":"BF2402485_CR26","first-page":"1431","volume":"13","author":"H Abou Issa","year":"1993","unstructured":"Abou Issa H, Curley RW Jr, Panigot MJ, Wilcox KA, Webb TE . In vivo use of N-(4-hydroxyphenyl retinamide)-O-glucuronide as a breast cancer chemopreventive agent Anticancer Res 1993 13: 1431\u20131436","journal-title":"Anticancer Res"},{"key":"BF2402485_CR27","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1200\/JCO.1993.11.3.474","volume":"11","author":"MA Cobleigh","year":"1993","unstructured":"Cobleigh MA, Dowlatshahi K, Deutsch TA, Mehta RG, Moon RC, Minn F, Benson AB, Rademaker AW, Ashenhurst JB, Wade JL . Phase I\/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer J Clin Oncol 1993 11: 474\u2013477","journal-title":"J Clin Oncol"},{"key":"BF2402485_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/jnci\/86.2.138","volume":"86","author":"A Decensi","year":"1994","unstructured":"Decensi A, Bruno S, Costantini M, Torrisi R, Curotto A, Gatteschi B, Nicolo G, Polizzi A, Perloff M, Malone WF . Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point J Natl Cancer Inst 1994 86: 138\u2013140","journal-title":"J Natl Cancer Inst"},{"key":"BF2402485_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3835(94)90385-9","volume":"76","author":"N Tradati","year":"1994","unstructured":"Tradati N, Chiesa F, Rossi N, Grigolato R, Formelli F, Costa A, de Palo G . Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR) Cancer Lett 1994 76: 109\u2013111","journal-title":"Cancer Lett"},{"key":"BF2402485_CR30","first-page":"2032","volume":"54","author":"A Costa","year":"1994","unstructured":"Costa A, Formelli F, Chiesa F, Decensi A, de Palo G, Veronesi U . Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide Cancer Res 1994 54: 2032\u20132037","journal-title":"Cancer Res"},{"key":"BF2402485_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/jcb.240531038","volume":"17F","author":"F Chiesa","year":"1993","unstructured":"Chiesa F, Tradati N, Marazza M, Rossi N, Boracchi P, Mariani L, Formelli F, Giardini R, Costa A, de Palo G . Fenretinide (4-HPR) in chemoprevention of oral leukoplakia J Cell Biochem Suppl 1993 17F: 255\u2013261","journal-title":"J Cell Biochem Suppl"},{"key":"BF2402485_CR32","first-page":"176","volume":"20","author":"GJ Kelloff","year":"1994","unstructured":"Kelloff GJ, Crowell JA, Boone CW, Steele VE, Lubet RA, Greenwald P, Alberts DS, Covey JM, Doody LA, Knapp GG . Clinical development plan: N-(4-hydroxyphenyl)retinamide J Cell Biochem Suppl 1994 20: 176\u2013196","journal-title":"J Cell Biochem Suppl"},{"key":"BF2402485_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/carcin\/18.5.943","volume":"18","author":"D Delia","year":"1997","unstructured":"Delia D, Aiello A, Meroni L, Nicolini M, Reed JC, Pierotti MA . Role of antioxidants and intracellular free radicals in retinamide-induced cell death Carcinogenesis 1997 18: 943\u2013948","journal-title":"Carcinogenesis"},{"key":"BF2402485_CR34","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/jnci\/92.23.1897","volume":"92","author":"BJ Maurer","year":"2000","unstructured":"Maurer BJ, Melton L, Billups C, Cabot MC, Reynolds CP . Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydro-xyphenyl)retinamide and modulators of ceramide metabolism J Natl Cancer Inst 2000 92: 1897\u20131909","journal-title":"J Natl Cancer Inst"},{"key":"BF2402485_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<53::AID-IJC10>3.0.CO;2-6","volume":"78","author":"A Dipietrantonio","year":"1998","unstructured":"Dipietrantonio A, Hsieh T-C, Olson SC, Wu JM . Regulation of G1\/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR) Int J Cancer 1998 78: 53\u201361","journal-title":"Int J Cancer"},{"key":"BF2402485_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.185.3.481","volume":"185","author":"GS Dbaibo","year":"1997","unstructured":"Dbaibo GS, Perry DK, Gamard CJ, Platt R, Poirier GG, Obeid LM, Hannun YA . Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway J Exp Med 1997 185: 481\u2013490","journal-title":"J Exp Med"},{"key":"BF2402485_CR37","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1074\/jbc.273.5.2910","volume":"273","author":"O Cuvillier","year":"1998","unstructured":"Cuvillier O, Rosenthal DS, Smulson ME, Spiegel S . Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes J Biol Chem 1998 273: 2910\u20132916","journal-title":"J Biol Chem"},{"key":"BF2402485_CR38","doi-asserted-by":"publisher","first-page":"11369","DOI":"10.1074\/jbc.272.17.11369","volume":"272","author":"C Garcia-Ruiz","year":"1997","unstructured":"Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC . Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione J Biol Chem 1997 272: 11369\u201311377","journal-title":"J Biol Chem"},{"key":"BF2402485_CR39","doi-asserted-by":"publisher","first-page":"21388","DOI":"10.1074\/jbc.272.34.21388","volume":"272","author":"A Quillet-Mary","year":"1997","unstructured":"Quillet-Mary A, Jaffrezou JP, Mansat V, Bordier C, Naval J, Laurent G . Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis J Biol Chem 1997 272: 21388\u201321395","journal-title":"J Biol Chem"},{"key":"BF2402485_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1042\/bj3350465","volume":"335","author":"S Mathias","year":"1998","unstructured":"Mathias S, Pena LA, Kolesnick RN . Signal transduction of stress via ceramide Biochem J 1998 335: 465\u2013480","journal-title":"Biochem J"},{"key":"BF2402485_CR41","doi-asserted-by":"publisher","first-page":"20296","DOI":"10.1074\/jbc.274.29.20296","volume":"274","author":"PP Ruvolo","year":"1999","unstructured":"Ruvolo PP, Deng X, Ito T, Carr BK, May WS . Ceramide induces Bcl2 dephosporylation via a mechanism involving mitochondrial PP2A J Biol Chem 1999 274: 20296\u201320300","journal-title":"J Biol Chem"},{"key":"BF2402485_CR42","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1146\/annurev.physiol.60.1.643","volume":"60","author":"RN Kolesnick","year":"1998","unstructured":"Kolesnick RN, Kronke M . Regulation of ceramide production and apoptosis (review) Annu Rev Physiol 1998 60: 643\u2013665","journal-title":"Annu Rev Physiol"},{"key":"BF2402485_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0076-6879(00)11065-1","volume":"311","author":"JA Shayman","year":"2000","unstructured":"Shayman JA, Abe A . Glucosylceramide synthase: assay and properties Methods Enzymol 2000 311: 42\u201349","journal-title":"Methods Enzymol"},{"key":"BF2402485_CR44","doi-asserted-by":"publisher","first-page":"8467","DOI":"10.1074\/jbc.273.14.8467","volume":"273","author":"A Abe","year":"1998","unstructured":"Abe A, Shayman JA . Purification and characterization of 1-O-acylceramide synthase, a novel phospholipase A2 with transacylase activity J Biol Chem 1998 273: 8467\u20138474","journal-title":"J Biol Chem"},{"key":"BF2402485_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0076-6879(00)11097-3","volume":"311","author":"JA Shayman","year":"2000","unstructured":"Shayman JA, Lee L, Abe A, Shu L . Inhibitors of glucosylceramide synthase Methods Enzymol 2000 311: 373\u2013387","journal-title":"Methods Enzymol"},{"key":"BF2402485_CR46","doi-asserted-by":"publisher","first-page":"14662","DOI":"10.1074\/jbc.274.21.14662","volume":"274","author":"L Lee","year":"1999","unstructured":"Lee L, Abe A, Shayman JA . Improved inhibitors of glucosylceramide synthase J Biol Chem 1999 274: 14662\u201314669","journal-title":"J Biol Chem"},{"key":"BF2402485_CR47","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0145-2126(94)90089-2","volume":"18","author":"AR Cattan","year":"1994","unstructured":"Cattan AR, Douglas E . The C.B.17 scid mouse strain as a model for human disseminated leukaemia and myeloma in vivo Leuk Res 1994 18: 513\u2013522","journal-title":"Leuk Res"},{"key":"BF2402485_CR48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/0014-4827(66)90079-6","volume":"43","author":"DO Schachtschabel","year":"1966","unstructured":"Schachtschabel DO, Lazarus H, Farber S, Foley GE . Sensitivity of cultured human lymphoblasts (CCRF-CEM cells) to inhibition by thymidine Exp Cell Res 1966 43: 512\u2013514","journal-title":"Exp Cell Res"},{"key":"BF2402485_CR49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0145-2126(82)90091-1","volume":"6","author":"T LeBien","year":"1982","unstructured":"LeBien T, Kersey J, Nakazawa S, Minato K, Minowada J . Analysis of human leukemia\/lymphoma cell lines with monoclonal antibodies BA-1, BA-2 and BA-3 Leuk Res 1982 6: 299\u2013305","journal-title":"Leuk Res"},{"key":"BF2402485_CR50","first-page":"193","volume":"516","author":"M Greaves","year":"1978","unstructured":"Greaves M, Janossy G . Patterns of gene expression and the cellular origins of human leukaemias Biochim Biophys Acta 1978 516: 193\u2013230","journal-title":"Biochim Biophys Acta"},{"key":"BF2402485_CR51","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4049\/jimmunol.126.2.596","volume":"126","author":"RG Smith","year":"1981","unstructured":"Smith RG, Dev VG, Shannon WAJ . Characterization of a novel human pre-B leukemia cell line J Immunol 1981 126: 596\u2013602","journal-title":"J Immunol"},{"key":"BF2402485_CR52","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/1097-0142(197711)40:5<2131::AID-CNCR2820400523>3.0.CO;2-V","volume":"40","author":"S Hiraki","year":"1977","unstructured":"Hiraki S, Miyoshi I, Kubonishi I, Matsuda Y, Nakayama T, Kishimoto H, Masuji H . Human leukemic \u2018null\u2019 cell line (NALL-1) Cancer 1977 40: 2131\u20132135","journal-title":"Cancer"},{"key":"BF2402485_CR53","first-page":"891","volume":"49","author":"J Minowada","year":"1972","unstructured":"Minowada J, Onuma T, Moore GE . Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes J Natl Cancer Inst 1972 49: 891\u2013895","journal-title":"J Natl Cancer Inst"},{"key":"BF2402485_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0304-3835(93)90256-9","volume":"73","author":"VT Chow","year":"1993","unstructured":"Chow VT, Quek HH, Tock EP . Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line Cancer Lett 1993 73: 141\u2013148","journal-title":"Cancer Lett"},{"key":"BF2402485_CR55","first-page":"1331","volume":"42","author":"CP Reynolds","year":"1982","unstructured":"Reynolds CP, Reynolds DA, Frenkel EP, Smith RG . Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant Cancer Res 1982 42: 1331\u20131336","journal-title":"Cancer Res"},{"key":"BF2402485_CR56","first-page":"303","volume":"36","author":"T Fragala","year":"1995","unstructured":"Fragala T, Proffitt RT, Reynolds CP . A novel 96-well plate cytotoxicity assay based on fluorescence digital imaging microscopy Proc Amer Assoc Cancer Res 1995 36: 303","journal-title":"Proc Amer Assoc Cancer Res"},{"key":"BF2402485_CR57","first-page":"5396","volume":"58","author":"N Keshelava","year":"1998","unstructured":"Keshelava N, Seeger RC, Groshen S, Reynolds CP . Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy Cancer Res 1998 58: 5396\u20135405","journal-title":"Cancer Res"},{"key":"BF2402485_CR58","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1083\/jcb.66.1.188","volume":"66","author":"A Krishan","year":"1975","unstructured":"Krishan A . Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining J Cell Biol 1975 66: 188\u2013193","journal-title":"J Cell Biol"},{"key":"BF2402485_CR59","doi-asserted-by":"publisher","first-page":"19530","DOI":"10.1074\/jbc.271.32.19530","volume":"271","author":"Y Lavie","year":"1996","unstructured":"Lavie Y, Cao H-T, Bursten SL, Giuliano AE, Cabot MC . Accumulation of glucosylceramide in multidug-resistant cancer cells J Biol Chem 1996 271: 19530\u201319536","journal-title":"J Biol Chem"},{"key":"BF2402485_CR60","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1074\/jbc.272.3.1682","volume":"272","author":"Y Lavie","year":"1997","unstructured":"Lavie Y, Cao H, Volner A, Lucci A, Han T-Y, Geffen V, Giuliano AE, Cabot MC . Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells J Biol Chem 1997 272: 1682\u20131687","journal-title":"J Biol Chem"},{"key":"BF2402485_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0076-6879(00)11062-6","volume":"311","author":"E Wang","year":"2000","unstructured":"Wang E, Merrill AH Jr . Ceramide Synthase Methods Enzymol 2000 311: 15\u201321","journal-title":"Methods Enzymol"},{"key":"BF2402485_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0076-6879(00)11060-2","volume":"311","author":"RC Dickson","year":"2000","unstructured":"Dickson RC, Lester RL, Nagiec MM . Serine Palmitoyltransferase Methods Enzymol 2000 311: 3\u20139","journal-title":"Methods Enzymol"},{"key":"BF2402485_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0022-2143(98)90018-X","volume":"131","author":"T-C Chou","year":"1998","unstructured":"Chou T-C . Drug combinations: From laboratory to practice J Lab Clin Med 1998 131: 6\u20138","journal-title":"J Lab Clin Med"},{"key":"BF2402485_CR64","first-page":"92","volume":"40","author":"PG Bagniewski","year":"1999","unstructured":"Bagniewski PG, Reid JM, Villablanca JG, Reynolds CP, Ames MM . A phase I pharmacokinetic study of fenretinide (HPR) in children with high-risk tumors Proc Amer Assoc Cancer Res 1999 40: 92","journal-title":"Proc Amer Assoc Cancer Res"},{"key":"BF2402485_CR65","first-page":"3729","volume":"5","author":"RE Parchment","year":"1999","unstructured":"Parchment RE, Jasti BR, Koracek TA, Wiegand RA, Kassab J, Wurster W, Keyes KA, Grieshaber CK, LoRusso PM . Pharmacologic issues for fenretinide chemotherapy (4-HPR, NSC-374551). Proceedings of the 1999 AACR-NCI-EORTC International Conference Clin Cancer Res Suppl 1999 5: 3729\u20133897 No. 350","journal-title":"Clin Cancer Res Suppl"},{"key":"BF2402485_CR66","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0076-6879(92)09053-6","volume":"209","author":"AH Merrill Jr","year":"1992","unstructured":"Merrill AH Jr, Wang E . Enzymes of ceramide biosynthesis Methods Enzymol 1992 209: 427\u2013437","journal-title":"Methods Enzymol"},{"key":"BF2402485_CR67","first-page":"1179","volume":"41","author":"K Tamiya-Koizumi","year":"1997","unstructured":"Tamiya-Koizumi K, Murate T, Suzuki M, Simbulan CM, Nakagawa M, Takemura M, Furuta K, Izuta S, Yoshida S . Inhibition of DNA primase by sphingosine and its analogues parallels with their growth suppression of cultured human leukemic cells Biochem Mol Biol Int 1997 41: 1179\u20131189","journal-title":"Biochem Mol Biol Int"},{"key":"BF2402485_CR68","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0145-2126(98)00107-6","volume":"22","author":"J Klostergaard","year":"1998","unstructured":"Klostergaard J, Auzenne E, Leroux E . Characterization of cytotoxicity induced by sphingolipids in multidrug-resistant leukemia cells Leuk Res 1998 22: 1049\u20131056","journal-title":"Leuk Res"},{"key":"BF2402485_CR69","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00008390-199806000-00005","volume":"8","author":"E Auzenne","year":"1998","unstructured":"Auzenne E, Leroux ME, Hu M, Pollock RE, Feig B, Klostergaard J . Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro Melanoma Res 1998 8: 227\u2013239","journal-title":"Melanoma Res"},{"key":"BF2402485_CR70","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1124\/mol.52.6.935","volume":"52","author":"WD Jarvis","year":"1997","unstructured":"Jarvis WD, Fornari FA Jr, Auer KL, Freemerman AJ, Szabo E, Birrer MJ, Johnson CR, Barbour SE, Dent P, Grant S . Coordinate regulation of stress- and mitogen-actived protein kinases in the apoptotic actions of ceramide and sphingosine Mol Pharmacol 1997 52: 935\u2013947","journal-title":"Mol Pharmacol"},{"key":"BF2402485_CR71","doi-asserted-by":"publisher","first-page":"8275","DOI":"10.1074\/jbc.271.14.8275","volume":"271","author":"WD Jarvis","year":"1996","unstructured":"Jarvis WD, Fornari FA, Traylor RS, Martin HA, Kramer LB, Erukulla RK, Bittman R, Grant S . Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells J Biol Chem 1996 271: 8275\u20138284","journal-title":"J Biol Chem"},{"key":"BF2402485_CR72","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1074\/jbc.274.2.1140","volume":"274","author":"Y-Y Liu","year":"1999","unstructured":"Liu Y-Y, Han T-Y, Giuliano AE, Cabot MC . Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells J Biol Chem 1999 274: 1140\u20131146","journal-title":"J Biol Chem"},{"key":"BF2402485_CR73","doi-asserted-by":"publisher","first-page":"34810","DOI":"10.1074\/jbc.M005142200","volume":"275","author":"AD Tepper","year":"2000","unstructured":"Tepper AD, Diks SH, van Blitterswijk WJ, Borst J . Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens J Biol Chem 2000 275: 34810\u201334817","journal-title":"J Biol Chem"},{"key":"BF2402485_CR74","first-page":"5102","volume":"61","author":"H Wang","year":"2001","unstructured":"Wang H, Maurer BJ, Reynolds CP, Cabot MC . N-(4-hydro-xyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase Cancer Res 2001 61: 5102\u20135105","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402485","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T01:56:12Z","timestamp":1682042172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5,1]]}},"alternative-id":["BF2402485"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402485","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5,1]]},"assertion":[{"value":"13 October 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}